Adverse Drug Events Reporting

Adverse Drug Events Reporting News

FDA Okays First Generics for MS Drug Fingolimod (Gilenya) The FDA granted three companies approval to market generic copies of fingolimod (Gilenya), the first oral disease-modifying multiple sclerosis therapy approved in 2010.
Medscape Medical News, December 2019
IDF 2019 Is Strict Glycemic Control Meaningless for the Elderly? At the International Diabetes Federation 2019 Congress, two experts debate the controversial topic, revealing differing perspectives on benefits vs risks.
Medscape Medical News, December 2019

Highlights From ASN Kidney Week 2019 Highlights from ASN's Kidney Week 2019 include results from the CREDENCE trial showing benefit from the SGLT2 inhibitor canagliflozin for patients with established diabetic nephropathy.
Medscape, December 3, 2019
How About a Troubleshooting Guide for Patients? What would serve patients best would be a readily available checklist, says Dr Plotzker.
Medscape Diabetes & Endocrinology, November 27, 2019

Americans Are Dying Younger--Why?
Medscape, November 26, 2019
Oral Semaglutide Brings GLP-1s to Primary Care
Medscape Diabetes & Endocrinology, November 21, 2019
Tackling Radionecrosis After SRS for Brain Metastases
Medscape Oncology, November 20, 2019
Iron Supplementation: How Much Is Enough?
Medscape Internal Medicine, November 15, 2019

Prescription Medication Sharing: A Systematic Review
American Journal of Public Health, May 29, 2014
Drug-Induced Neurologic Conditions
U.S. Pharmacist, April 22, 2014
Fixed Drug Eruption Associated With Sulfonamides
Morbidity & Mortality Weekly Report, December 24, 2013
Inappropriate Medication Prescriptions in Elderly Adults
Journal of the American Geriatrics Society, August 14, 2013
The Aspirin Cardiovascular/GI Risk Calculator
Alimentary Pharmacology & Therapeutics, April 2, 2013